_id
6912ff89ccc777a4e85d7878
Ticker
ICUCW
Name
LMF Acquisition Opportunities Inc
Exchange
NASDAQ
Address
3513 Brighton Boulevard, Denver, CO, United States, 80216
Country
USA
Sector
Industry
Currency
USD
Website
https://seastarmedical.com
Description
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Last Close
0.0375
Volume
63556
Current Price
0.02
Change
-0.0007
Last Updated
2026-01-04T14:58:54.164Z
Image
data:image/webp;base64,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
Ipo Date
2021-03-18T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
183000
Cost Of Revenue
14000
Gross Profit
169000
Operating Expenses
3748000
Operating Income
-3579000
Interest Expense
0
Pretax Income
-3472000
Net Income
-3472000
Eps
-0.13154803852478272
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-3465000
Operating Margin
-1955.7377049180327
Total Other Income Expense Net
107000
Cash
13763000
Short Term Investments
-
Receivables
221000
Inventories
83000
Total Current Assets
14874000
Property Plant Equipment
-
Total Assets
15530000
Payables
2018000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4066000
Equity
11464000
Bs_currency_symbol
USD
Depreciation
7000
Change In Working Capital
-662000
Cash From Operations
-3844000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
11305000
Net Change In Cash
7461000
Cf_currency_symbol
USD
PE
-
PB
0.046045708304256805
ROE
-30.286113049546405
ROA
-22.356728911783645
FCF
-3844000
Fcf Percent
-21.005464480874316
Piotroski FScore
0
Health Score
33
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
2
Quality Investing Score
3
Value Investing Score
7
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
183000
Quarters > 0 > income Statement > cost Of Revenue
14000
Quarters > 0 > income Statement > gross Profit
169000
Quarters > 0 > income Statement > operating Expenses
3748000
Quarters > 0 > income Statement > operating Income
-3579000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-3472000
Quarters > 0 > income Statement > net Income
-3472000
Quarters > 0 > income Statement > eps
-0.13154803852478272
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
26393400
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3465000
Quarters > 0 > income Statement > operating Margin
-1955.7377049180327
Quarters > 0 > income Statement > total Other Income Expense Net
107000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
13763000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
221000
Quarters > 0 > balance Sheet > inventories
83000
Quarters > 0 > balance Sheet > total Current Assets
14874000
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
15530000
Quarters > 0 > balance Sheet > payables
2018000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4066000
Quarters > 0 > balance Sheet > equity
11464000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3472000
Quarters > 0 > cash Flow > depreciation
7000
Quarters > 0 > cash Flow > change In Working Capital
-662000
Quarters > 0 > cash Flow > cash From Operations
-3844000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
11305000
Quarters > 0 > cash Flow > net Change In Cash
7461000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.13154803852478272
Quarters > 0 > ratios > PB
0.046045708304256805
Quarters > 0 > ratios > ROE
-30.286113049546405
Quarters > 0 > ratios > ROA
-22.356728911783645
Quarters > 0 > ratios > FCF
-3844000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-21.005464480874316
Quarters > 0 > health Score
33
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
338000
Quarters > 1 > income Statement > cost Of Revenue
27000
Quarters > 1 > income Statement > gross Profit
311000
Quarters > 1 > income Statement > operating Expenses
2067000
Quarters > 1 > income Statement > operating Income
-1756000
Quarters > 1 > income Statement > interest Expense
307000
Quarters > 1 > income Statement > pretax Income
-2002000
Quarters > 1 > income Statement > net Income
-2002000
Quarters > 1 > income Statement > eps
-0.11436275041843513
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
17505700
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1993000
Quarters > 1 > income Statement > operating Margin
-519.5266272189349
Quarters > 1 > income Statement > total Other Income Expense Net
-246000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6302000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
217000
Quarters > 1 > balance Sheet > inventories
77000
Quarters > 1 > balance Sheet > total Current Assets
7647000
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
8383000
Quarters > 1 > balance Sheet > payables
3158000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
5042000
Quarters > 1 > balance Sheet > equity
3341000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2002000
Quarters > 1 > cash Flow > depreciation
7000
Quarters > 1 > cash Flow > change In Working Capital
-1391000
Quarters > 1 > cash Flow > cash From Operations
-3007000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
4013000
Quarters > 1 > cash Flow > net Change In Cash
1006000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.11436275041843513
Quarters > 1 > ratios > PB
0.10479317569589944
Quarters > 1 > ratios > ROE
-59.92217898832685
Quarters > 1 > ratios > ROA
-23.881665274961232
Quarters > 1 > ratios > FCF
-3007000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-8.896449704142011
Quarters > 1 > health Score
23
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
293000
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
293000
Quarters > 2 > income Statement > operating Expenses
4115000
Quarters > 2 > income Statement > operating Income
-3822000
Quarters > 2 > income Statement > interest Expense
11000
Quarters > 2 > income Statement > pretax Income
-3769000
Quarters > 2 > income Statement > net Income
-3772000
Quarters > 2 > income Statement > eps
-0.43768855883035507
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
8618000
Quarters > 2 > income Statement > income Tax Expense
3000
Quarters > 2 > income Statement > EBITDA
-3758000
Quarters > 2 > income Statement > operating Margin
-1304.4368600682594
Quarters > 2 > income Statement > total Other Income Expense Net
53000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
5296000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
110000
Quarters > 2 > balance Sheet > inventories
44000
Quarters > 2 > balance Sheet > total Current Assets
6784000
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
7597000
Quarters > 2 > balance Sheet > payables
3397000
Quarters > 2 > balance Sheet > short Term Debt
363000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
7032000
Quarters > 2 > balance Sheet > equity
565000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3772000
Quarters > 2 > cash Flow > depreciation
11000
Quarters > 2 > cash Flow > change In Working Capital
956000
Quarters > 2 > cash Flow > cash From Operations
-2654000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
6131000
Quarters > 2 > cash Flow > net Change In Cash
3477000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.43768855883035507
Quarters > 2 > ratios > PB
0.30506194690265487
Quarters > 2 > ratios > ROE
-667.6106194690266
Quarters > 2 > ratios > ROA
-49.65117809661709
Quarters > 2 > ratios > FCF
-2654000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-9.058020477815699
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
67000
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
67000
Quarters > 3 > income Statement > operating Expenses
4834000
Quarters > 3 > income Statement > operating Income
-4767000
Quarters > 3 > income Statement > interest Expense
-253000
Quarters > 3 > income Statement > pretax Income
-4419000
Quarters > 3 > income Statement > net Income
-4419000
Quarters > 3 > income Statement > eps
-0.8981707317073171
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4920000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-4672000
Quarters > 3 > income Statement > operating Margin
-7114.925373134328
Quarters > 3 > income Statement > total Other Income Expense Net
348000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1819000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
112000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3766000
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
4658000
Quarters > 3 > balance Sheet > payables
3046000
Quarters > 3 > balance Sheet > short Term Debt
574000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
6841000
Quarters > 3 > balance Sheet > equity
-2183000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-4419000
Quarters > 3 > cash Flow > depreciation
-27000
Quarters > 3 > cash Flow > change In Working Capital
-410000
Quarters > 3 > cash Flow > cash From Operations
-4693000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
4430000
Quarters > 3 > cash Flow > net Change In Cash
-263000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.8981707317073171
Quarters > 3 > ratios > PB
-0.045075584058634904
Quarters > 3 > ratios > ROE
202.42785158039393
Quarters > 3 > ratios > ROA
-94.86904250751395
Quarters > 3 > ratios > FCF
-4693000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-70.04477611940298
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
135000
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
135000
Annuals > 0 > income Statement > operating Expenses
17977000
Annuals > 0 > income Statement > operating Income
-17842000
Annuals > 0 > income Statement > interest Expense
244000
Annuals > 0 > income Statement > pretax Income
-24827000
Annuals > 0 > income Statement > net Income
-24830000
Annuals > 0 > income Statement > eps
-6.631944444444445
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3744000
Annuals > 0 > income Statement > income Tax Expense
3000
Annuals > 0 > income Statement > EBITDA
-24583000
Annuals > 0 > income Statement > operating Margin
-13216.296296296296
Annuals > 0 > income Statement > total Other Income Expense Net
-6985000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1819000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
112000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3766000
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
4658000
Annuals > 0 > balance Sheet > payables
3046000
Annuals > 0 > balance Sheet > short Term Debt
574000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6841000
Annuals > 0 > balance Sheet > equity
-2183000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-24830000
Annuals > 0 > cash Flow > depreciation
17842000
Annuals > 0 > cash Flow > change In Working Capital
992000
Annuals > 0 > cash Flow > cash From Operations
-16007000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
17650000
Annuals > 0 > cash Flow > net Change In Cash
1643000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-6.631944444444445
Annuals > 0 > ratios > PB
-0.01817975263398992
Annuals > 0 > ratios > ROE
1137.4255611543747
Annuals > 0 > ratios > ROA
-533.0613997423786
Annuals > 0 > ratios > FCF
-16007000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-118.57037037037037
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
14210000
Annuals > 1 > income Statement > operating Income
-14210000
Annuals > 1 > income Statement > interest Expense
1081000
Annuals > 1 > income Statement > pretax Income
-26232000
Annuals > 1 > income Statement > net Income
-26232000
Annuals > 1 > income Statement > eps
-30.26258258701704
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
866813
Annuals > 1 > income Statement > income Tax Expense
-14010
Annuals > 1 > income Statement > EBITDA
-11141000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-12022000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
176000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
0
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2308000
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
3513000
Annuals > 1 > balance Sheet > payables
4372000
Annuals > 1 > balance Sheet > short Term Debt
4744000
Annuals > 1 > balance Sheet > long Term Debt
4337000
Annuals > 1 > balance Sheet > total Liabilities
17383000
Annuals > 1 > balance Sheet > equity
-13870000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-26232000
Annuals > 1 > cash Flow > depreciation
14010000
Annuals > 1 > cash Flow > change In Working Capital
2877000
Annuals > 1 > cash Flow > cash From Operations
-10285000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
10414000
Annuals > 1 > cash Flow > net Change In Cash
129000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-30.26258258701704
Annuals > 1 > ratios > PB
-0.0006624526171593367
Annuals > 1 > ratios > ROE
189.12761355443405
Annuals > 1 > ratios > ROA
-746.7122117847994
Annuals > 1 > ratios > FCF
-10285000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
11609000
Annuals > 2 > income Statement > operating Income
-11609000
Annuals > 2 > income Statement > interest Expense
630000
Annuals > 2 > income Statement > pretax Income
-23012000
Annuals > 2 > income Statement > net Income
-23013000
Annuals > 2 > income Statement > eps
-44.142272656650114
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
521337
Annuals > 2 > income Statement > income Tax Expense
1000
Annuals > 2 > income Statement > EBITDA
-11609000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-10773000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
47000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
12000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1519000
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
3038000
Annuals > 2 > balance Sheet > payables
1927000
Annuals > 2 > balance Sheet > short Term Debt
1178000
Annuals > 2 > balance Sheet > long Term Debt
7652000
Annuals > 2 > balance Sheet > total Liabilities
23800000
Annuals > 2 > balance Sheet > equity
-20762000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-12190000
Annuals > 2 > cash Flow > depreciation
11609
Annuals > 2 > cash Flow > change In Working Capital
2552000
Annuals > 2 > cash Flow > cash From Operations
-7794000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
7331000
Annuals > 2 > cash Flow > net Change In Cash
-463000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-44.142272656650114
Annuals > 2 > ratios > PB
-0.00026616762354301127
Annuals > 2 > ratios > ROE
110.84192274347366
Annuals > 2 > ratios > ROA
-757.5049374588546
Annuals > 2 > ratios > FCF
-7794000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
4449000
Annuals > 3 > income Statement > operating Income
-4449000
Annuals > 3 > income Statement > interest Expense
212000
Annuals > 3 > income Statement > pretax Income
-4597000
Annuals > 3 > income Statement > net Income
-4596000
Annuals > 3 > income Statement > eps
-8.810674028065332
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
521640
Annuals > 3 > income Statement > income Tax Expense
-1000
Annuals > 3 > income Statement > EBITDA
-4385000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-148000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
510000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
58000
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
601000
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
603000
Annuals > 3 > balance Sheet > payables
85000
Annuals > 3 > balance Sheet > short Term Debt
2378000
Annuals > 3 > balance Sheet > long Term Debt
244000
Annuals > 3 > balance Sheet > total Liabilities
3419000
Annuals > 3 > balance Sheet > equity
-2816000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-4596000
Annuals > 3 > cash Flow > depreciation
4449000
Annuals > 3 > cash Flow > change In Working Capital
-680000
Annuals > 3 > cash Flow > cash From Operations
-5114000
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-105570000
Annuals > 3 > cash Flow > cash From Financing
2817000
Annuals > 3 > cash Flow > net Change In Cash
471612
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-8.810674028065332
Annuals > 3 > ratios > PB
-0.001963559659090909
Annuals > 3 > ratios > ROE
163.21022727272728
Annuals > 3 > ratios > ROA
-762.1890547263682
Annuals > 3 > ratios > FCF
-5114000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.13154803852478272
Valuation > metrics > PB
0.046045708304256805
Valuation > final Score
70
Valuation > verdict
95.4% Undervalued
Profitability > metrics > ROE
-30.286113049546405
Profitability > metrics > ROA
-23.34274573080543
Profitability > metrics > Net Margin
-18.972677595628415
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.354675505931612
Risk > metrics > Interest Coverage
-511.2857142857143
Risk > final Score
-1985
Risk > verdict
High
Liquidity > metrics > Current Ratio
7.370664023785927
Liquidity > metrics > Quick Ratio
7.329534192269574
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
40
Prev Risks > 0
7
Prev Risks > 1
-1384
Prev Risks > 2
-45
Prev Liquidities > 0
100
Prev Liquidities > 1
95
Prev Liquidities > 2
76
Updated At
2026-01-20T22:00:49.756Z
SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ABreakout Move: What is the Moat Score of ICUCW - Weekly Risk Report & Consistent Profit Trade Alerts baoquankhu1.vn
Read more →Tech Rally: Is ICUCW benefiting from interest rate changes - Watch List & Stock Market Timing Techniques baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of LMF Acquisition Opportunities Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.